Managers / Q2 2022 · view latest →
EMERALD ADVISERS, LLC
CIK 0001015083 · 3175 OREGON PIKE, LEOLA, PA, 17540 · 717-556-8900
Reported Value
$1.9B
Q2 2022
Positions
250
Filings on Record
30
2019–present window
Filed
Jul 29, 2022
original filing
Summary
Emerald Advisers, LLC reported $1.9B in U.S.-listed holdings across 250 positions for Q2 2022.
Its largest position, GTLS, represents 3.0% of the portfolio.
Compared with Q1 2022, the fund opened 21 new positions and exited 33.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 92.9% · $1.8B
- Other · 6.5% · $127M
- REIT · 0.5% · $11M
- ETP · 0.0% · $53,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ALKERMES PLC | NEW | +1.04M | 1.04M | +$31M | $31M |
| TNDMTANDEM DIABETES CARE INC | NEW | +400.9K | 400.9K | +$24M | $24M |
| LNTHLANTHEUS HOLDINGS INC | NEW | +346.5K | 346.5K | +$23M | $23M |
| ACDCPROFRAC HOLDING CORP | NEW | +875.0K | 875.0K | +$16M | $16M |
| EXPOEXPONENT INC | NEW | +149.4K | 149.4K | +$14M | $14M |
| EEEXCELERATE ENERGY INC | NEW | +602.7K | 602.7K | +$12M | $12M |
| ALGTALLEGIANT TRAVEL CO | NEW | +67.8K | 67.8K | +$8M | $8M |
| CYTKCYTOKENETICS INC | NEW | +144.3K | 144.3K | +$6M | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2022
50 positions
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $3.2B | 248 | May 4, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $3.2B | 246 | Feb 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $3.1B | 257 | Oct 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $2.7B | 248 | Aug 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $2.2B | 243 | May 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.6B | 254 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $2.6B | 248 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.4B | 247 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.5B | 243 | May 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $2.3B | 242 | Feb 5, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $2.1B | 232 | Oct 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.3B | 211 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $2.1B | 210 | May 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $2.1B | 246 | Feb 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.9B | 249 | Oct 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.9B | 250 | Jul 29, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.6B | 262 | Apr 29, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.7B | 281 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $2.8B | 235 | Oct 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.7B | 287 | Jul 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.8B | 242 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $3.0B | 286 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.4B | 334 | Oct 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $2.3B | 318 | Jul 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.7B | 213 | Apr 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.4B | 338 | Jan 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $2.1B | 245 | Oct 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.5B | 250 | Jul 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.5B | 251 | May 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.0B | 244 | Jan 30, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.